Green Cross Corp is a top player in the Pharmaceuticals industry, headquartered in South Korea. With a low risk ESG score of 18.7, the company specializes in developing essential healthcare solutions like intravenous immunoglobulin (IVIG) and albumin. Known for its global presence and subsidiaries, Green Cross Corp is a key player in promoting sustainability and governance in the healthcare sector.